Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2017. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 100369701000001112 | Velpatasvir (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 100369801000001115 | Velpatasvir | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Velpatasvir | Is a | Substance with Hepatitis C virus protein NS5A inhibitor mechanism of action | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Sofosbuvir 400mg / Velpatasvir 100mg tablets | Has specific active ingredient | False | Velpatasvir | Inferred relationship | Existential restriction modifier | |
| Epclusa 400mg/100mg tablets (Gilead Sciences Ltd) | Has specific active ingredient | False | Velpatasvir | Inferred relationship | Existential restriction modifier | |
| Sofosbuvir 400mg / Velpatasvir 100mg tablets 28 tablet | Has specific active ingredient | False | Velpatasvir | Inferred relationship | Existential restriction modifier | |
| Epclusa 400mg/100mg tablets (Gilead Sciences Ltd) 28 tablet | Has specific active ingredient | False | Velpatasvir | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR